An empirical assay for assessing genomic sensitivity and for improving cancer diagnostics
Detection tests have been developed for many cancers, but there is no
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Detection tests have been developed for many cancers, but there is no
Detection tests have been developed for many cancers, but there is no
Sensitivity and specificity of the empirical lymphocyte genome sensitivity (LGS) assay: implications for improving cancer diagnostics. The FASEB Journal article
Detection tests have been developed for many cancers, but there is no
Detection tests have been developed for many cancers, but there is no
immunoglobulin heavy chains were clearly demonstrated as a potentially useful pan cancer marker for cancer diagnostics and/ or monitoring cancer patients. CA215-based enzyme immunoassay kits are also beneficial
NSC 631570 (the mixture of alkaloids from C. majus) has shown anticancer
Upconverting nanoparticles (UCNPs) are promising new generation of imaging probes capable of
Detection tests have been developed for many cancers, but there is no
care in the coming years. However, the disruption of how cancer is managed is not straightforward. Although core diagnostics technologies, which have been tested established in a lab based environment
cancers and associated with cancer development and progression, revealing their potential for diagnostic and prognostic biomarkers in cancer. In this review, we will summarize the most important lncRNAs, focusing…
fundamental limitations of the state of art techniques used in vitro diagnostics of infectious diseases and cancer
considered as the base for creating of serological test-system for non-invasive breast cancer diagnostics in future
technology are making significant impact to applied markets. The large volume of data on cancer genomes is increasing our knowledge base to try and interpret the causes and possibly reveal ... promising to revolutionize…
Background: Molecular markers can be used to identify tumour at the surgical
benefits of the determination of human epididymis protein 4 (HE4) in the endometrial cancer diagnostics. We compared HE4 with cancer antigen 125 (CA125). Methods: The total number of females ... Diagnostics, Sweden)…
Detection tests have been developed for many cancers, but there is no
personalized therapeutics based on a patient?s genetic composition is a challenge, particularly in cancer diagnostics. In many cancers, the genetic composition can vary significantly within the same tumor sample…
ovarian cancer. We reasoned that appearance of autoantibody biomarkers was more likely to precede the detection serum proteins that are secreted in proportion to tumor size. Autoantibody diagnostics provide ... early…
E arly and non-invasive diagnosis and prognosis are important but challenging
below the bladder. It follows a natural course, starting as a tiny group of cancer cells that can grow into a full-blown tumour. In some men if PC that ... surrounding tissue by a process called metastases and could…
For authors and organisers
Find the right journal for your paper and submit your manuscript.